We develop, manufacture and market a broad range of branded and non-branded generic medicines.
NOVAK Products
®
Providing Quality Medicines Across the Global
As we look ahead, we are building a differentiated portfolio that anticipates future health needs. This ambition is being realized as we add complex and specialty products to our portfolio and pipeline and is fundamental to ensuring we continue to grow.
Generics
we have grown Generics revenue at a CAGR of 6% and, through our continuous focus on optimizing our cost base and driving operating efficiencies.
we are demonstrating our ability to more than offset competitive pressures through our strong commercial and manufacturing capabilities and the successful execution of our pipeline.
Injectables
Our Injectables business achieved good growth in 2021 across all our regions.
We remain focused on having a portfolio fit for the future, with the ongoing new launches. We already have great experience commercializing Injectables in MENA, where there are many injectables products that contributed to our growth in 2021. Also, there is good growth in the Europe market, as we increase the supply of our own injectables products.
Branded
In our Branded business, we have continued to strengthen our market position across the regions. Our strategy of tiering these markets – focusing investment in various markets across different regions with the highest potential. We have also built on our in-house R&D efforts and our pipeline of our own branded generics.
Whether you're a distributor, career seeker, medical professional, or an investor, you can contact us through the below global NOVAK email:
(Switzerland I Global)
Monday - Friday
8:30 a.m. - 5:00 p.m. GMT+1
For product-related inquiries and medical information about our products, please contact the NOVAK office in your country.
© 2022 by NOVAK Pharmaceuticals.
Our website uses cookies to improve your experience. Some of the cookies we use are essential for parts of our website to operate. By using our website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.